
Frazier Healthcare Partners
51 portfolio companies · 7 on the map · $3B raised · 7 cities
Portfolio map
7 Frazier Healthcare Partners portfolio companies on the map.
Portfolio companies

Rocket Pharmaceuticals
Cranbury
Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.
Biotechnology$891.4MEst. 2015
Arcutis Biotherapeutics
Westlake Village
Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.
Biotechnology Research$833.5MEst. 2016
Scholar Rock
Cambridge
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Biotechnology$743MEst. 2012
Krystal Biotech
Pittsburgh
Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..
Biotechnology$546MEst. 2016
REGENXBIO
Rockville
REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.
Biotechnology ResearchPublicEst. 2008
Tarsus Pharmaceuticals
Irvine
Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.
Pharmaceutical ManufacturingPublicEst. 2017Hiring fastAnaptysBio
San Diego
AnaptysBio is a biotechnology company that develops antibody therapeutics based on somatic hypermutation.
Biotechnology ResearchPublicEst. 2005
More portfolio companies
43 more Frazier Healthcare Partners investments we track beyond the map — 51 tracked in total.
Day One BiopharmaceuticalsSouth San Francisco · Post-IPO Equity
Scilex Holding CompanyPalo Alto · Venture
Hummingbird BioscienceWoodlands · Series C
AlcrestaNewton · Series B
Iovance BiotherapeuticsNew York · Post-IPO Equity
Lassen TherapeuticsSan Diego · Series A
Radionetics OncologyCalifornia City · Seed
Avadel PharmaceuticalsDublin · Post-IPO Equity
Scout BioPhiladelphia · Series B
Iterum TherapeuticsDublin · Series B
VIVUSMountain View · Venture
Passage BioPhiladelphia · Series B
Alpine Immune SciencesSeattle · Post-IPO Equity
Outpost MedicineIndianapolis · Series A
Sierra OncologySan Mateo · Series D
Molecular TemplatesAustin · Post-IPO Debt
ChimerixDurham · Series F
TricidaMenlo Park · Post-IPO Equity
EpizymeCambridge · Post-IPO Equity
ESSA PharmaVancouver · Post-IPO Equity
IVERIC bioPrinceton · Post-IPO Equity
Entasis TherapeuticsWaltham · Series B
Knipper HealthLakewood · Private Equity
Cerexa Inc.New York · Series A
AcertaPharmaSan Francisco · Series A
The CORE InstitutePhoenix · Private Equity
InnerPulseRaleigh · Venture
CalibriumCarmel · Convertible Note
PreCision DermatologyCumberland · Debt Financing
- CMCalibra MedicalRedwood City · Venture
SimpataLos Angeles · Series B
Incline TherapeuticsRedwood City · Series A
Zeltiq AestheticsPleasanton · Series D
CV TherapeuticsPalo Alto · Funding
Avera PharmaceuticalSan Diego · Series C
Quantum DotHayward · Series B
ZymoGeneticsSeattle · Funding
XenoportSanta Clara · Series A
Fast TrackSan Mateo · Series C
MEDCHANNELSan Francisco · Series B
CotherixSan Francisco · Series C
CorixaSeattle · Venture
TularikSan Francisco · Funding
Portfolio map
7 Frazier Healthcare Partners portfolio companies on the map.